Skip to content
UniqueBaseEN
For AI ↗
News

PathAI acquired by Roche as USD 1.05 billion

Read original source ↗
News
Stable identifier
d8e4f0bc-89a0-40bf-9907-fba4400b6039
News date
May 7, 2026
Funding estimate
$1.05B
Consideration (USD)
$1.1B
Source record updated
Oct 20, 2026
Snapshot captured
Oct 20, 2026
English updated
Oct 21, 2026
Original title

PathAI被罗氏以10.5亿美元收购

Translation dates do not change the dates of the underlying facts.

News brief

On 2026-5-7, according to Xiniu Data, PathAI was acquired. The investor is Roche Venture Fund. The company is a digital pathology service provider in the United States.

Connected profiles

Explore

Sources · 1

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

  1. 36kr.com ↗Published May 7, 2026
Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

2026年5月7日,据烯牛数据报道,PathAI被收购。投资方为Roche Venture Fund。该公司为美国数字病理服务提供商。